In the realm of chemical synthesis, particularly within the pharmaceutical sector, the utility of a compound is often defined by its purity and its specific functional properties. TAD-194, a high-purity pharmaceutical intermediate, excels in both these aspects, positioning itself as a valuable functional ingredient for a wide array of advanced chemical applications. Characterized as a white to light yellow powder with a purity exceeding 99%, TAD-194 is engineered to meet the demanding requirements of modern research and development.

The term 'functional ingredient' implies that TAD-194 actively contributes to the intended outcome of a chemical process or final product. In the context of pharmaceutical synthesis, this translates to its crucial role in building complex molecular structures with precision. Its consistent quality, backed by over 11 years of manufacturing expertise and international certifications like ISO9001, ensures that researchers can rely on its performance in demanding synthesis pathways.

The versatility of TAD-194 is evident in its applicability across different stages of chemical development. From early-stage research exploring novel molecular compounds to the scaled-up production of established pharmaceutical ingredients, its availability in quantities ranging from 1KG to 50KG caters to diverse project scales. This flexibility, combined with its high purity, makes it an attractive option for optimizing reaction yields and minimizing the need for extensive purification of downstream products.

Moreover, the 2-year shelf life of TAD-194 adds another layer of practicality for laboratories and manufacturing facilities, allowing for strategic inventory management. The inherent quality of this pharmaceutical intermediate, confirmed by its compliance with global standards such as MSDS and COA, ensures that it can be seamlessly integrated into rigorous quality control frameworks. For chemists and process engineers seeking dependable and high-performance raw materials, TAD-194 represents a robust solution for advancing their synthetic objectives.